| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 8.371 | 14.827 | 18.898 | 13.879 | 12.256 | 12.269 | 11.506 | 18.134 | 40.004 |
| Total Income - EUR | - | 8.373 | 14.827 | 18.898 | 13.879 | 12.256 | 12.269 | 11.506 | 18.134 | 40.004 |
| Total Expenses - EUR | - | 475 | 4.531 | 17.945 | 16.816 | 12.639 | 10.773 | 12.747 | 18.104 | 21.127 |
| Gross Profit/Loss - EUR | - | 7.898 | 10.296 | 953 | -2.937 | -383 | 1.497 | -1.241 | 31 | 18.877 |
| Net Profit/Loss - EUR | - | 7.647 | 9.851 | 668 | -3.045 | -722 | 1.128 | -1.455 | -147 | 17.701 |
| Employees | - | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Antalida Cell Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 19 | 18.247 | 14.074 | 10.038 | 6.155 | 2.407 | 0 | 0 | 30.490 |
| Current Assets | - | 7.770 | 14.384 | 16.389 | 13.447 | 12.200 | 7.360 | 6.854 | 23.283 | 5.161 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33 |
| Receivables | - | 0 | 0 | 0 | 0 | 13 | 13 | 0 | 0 | 969 |
| Cash | - | 7.770 | 14.384 | 16.389 | 13.447 | 12.187 | 7.348 | 6.854 | 23.283 | 4.160 |
| Shareholders Funds | - | 7.692 | 16.318 | 16.687 | 13.319 | 12.344 | 7.666 | 6.235 | 2.223 | 17.603 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 96 | 16.313 | 13.776 | 10.166 | 6.010 | 2.102 | 619 | 21.059 | 18.048 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Antalida Cell Srl